Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Neurology International|July 26, 2011
Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1aShlomo Flechter, Tirza Klein, Lea Pollak
The Israel Medical Association Journal : IMAJ|July 24, 2007
Cognitive dysfunction evaluation in multiple sclerosis patients treated with interferon beta-1b: an open-label prospective 1 year studyShlomo Flechter, Jacob Vardi, Yoram Finkelstein, et al.
American Journal of Otolaryngology|February 28, 2006
Approach to bilateral benign paroxysmal positioning vertigoLea Pollak, Rafael Stryjer, Mark Kushnir, et al.
The Israel Medical Association Journal : IMAJ|July 14, 2005
Approach to benign paroxysmal positional vertigo in old agePollak Lea, Mark Kushnir, Yizchak Shpirer, et al.
The Israel Medical Association Journal : IMAJ|January 15, 2004
Phobic postural vertigo: a new proposed entityLea Pollak, Colin Klein, Raphael Stryjer, et al.
The Journal of Orthopaedic and Sports Physical Therapy|March 6, 2015
The effect of additional ankle and midfoot mobilizations on plantar fasciitis: a randomized controlled trialAnat Shashua, Shlomo Flechter, Liat Avidan, et al.
Clinical Neuropharmacology|February 20, 2002
Copolymer 1 (glatiramer acetate) in relapsing forms of multiple sclerosis: open multicenter study of alternate-day administrationShlomo Flechter, Edna Kott, Bettina Steiner-Birmanns, et al.
Journal of Neuroimmunology|September 26, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4David Magalashvili, Mathilda Mandel, Sapir Dreyer-Alster, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|December 13, 2021
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patientsMichael Gurevich, Rina Zilkha-Falb, Polina Sonis, et al.
Journal of Neurology|March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimodAnat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Pageof 2